Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:16 AM
Ignite Modification Date:
2025-12-25 @ 1:16 AM
NCT ID:
NCT04164693
Eligibility Criteria:
Inclusion Criteria:
* After AVF formation or balloon dilation surgery, there were no significant signs of oozing or bleeding at the surgical incision and operative site observed within 12-24 hours.
* The patient is willing to accept short-term anticoagulant therapy after the surgery, bear related risks, and sign an informed consent form.
* The patient is willing to cooperate with this study, undergo data collection related to the research, and relevant clinical examinations.
Exclusion Criteria.
* Age \>80 years;
* Concurrent hematologic diseases that can affect coagulation function;
* Concurrent comorbidities that can affect the patient's bleeding or coagulation functions, such as liver cirrhosis;
* Concurrent active bleeding disorders, such as active gastrointestinal ulcers or active lupus;
* History of major organ bleeding (e.g., intracranial or gastrointestinal) or surgery within the past six months;
* Unwillingness to participate in this study.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
85 Years
Study:
NCT04164693
Study Brief:
Protocol Section:
NCT04164693